文献速递慢阻肺呼吸危重症与机械通气

慢阻肺急性加重无创通气三种照护模式比较:ACT3研究

Models of care for non-invasive ventilation in the Acute COPD Comparison of three Tertiary hospitals (ACT3) study.
PubMed 文献 · Respirology · 2017-12-10

这项前瞻性观察性非劣效研究在三个教学三级医院比较了普通病房、高依赖病房和ICU三种无创通气照护模式。普通病房模式在改善pH和PaCO2方面与HDU及ICU等效,且治疗更多患者、每日费用更低,但ICU住院时间更长。

要点

  • 普通病房NIV在改善pH和PaCO2方面与HDU及ICU等效。
  • 普通病房每日费用更低且治疗患者数更多。
  • 三模式间插管率和生存率无显著差异。

核心结论

  • 在急性高碳酸血症COPD患者中,普通病房NIV照护模式获得与HDU或ICU等效的临床结局,且更具成本效益。

研究设计与样本

  • 前瞻性观察性非劣效研究,在三个相似的教学三级医院比较普通病房、HDU和ICU三种NIV照护模式。
  • 普通病房护士与患者比为1:4、每周三次顾问查房;HDU为1:2、每日两次查房;ICU为1:1、每日两次查房。
  • 比较动脉血气变化和临床结局,并对AECOPD严重度(BAP-65)和合并症进行校正,同时进行经济学分析。

主要发现

  • 三种模式间年龄(70±10岁)、FEV1(0.84±0.35 L)、初始pH(7.29±0.08)、PaCO2(72±22 mm Hg)或BAP-65评分(2.9±1.01)无显著差异。
  • 普通病房实现pH升高(0.12±0.07)和PaCO2下降(12±18 mm Hg),与HDU和ICU等效。
  • 普通病房治疗患者更多(38 vs 28 vs 15,P<0.001),初始24小时内NIV时长更长(12.3±4.8 vs 7.9±4.1 vs 8.4±5.3 h,P<0.05)。
  • 普通病房每治疗日费用更低($AUD 1231±382 vs 1745±2673 vs 2386±1120,P<0.05)。
  • ICU住院时间更长(9±11 vs 7±7 vs 13±28天,P<0.002),插管率和生存率无显著差异。

临床怎么用

  • 对于急性高碳酸血症COPD患者,普通病房NIV照护模式可作为等效且更具成本效益的选择。

局限性

  • 本研究为前瞻性观察性研究,非随机对照设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Non-invasive ventilation (NIV) improves clinical outcomes in hypercapnic acute exacerbations of COPD (AECOPD), but the optimal model of care remains unknown. METHODS: We conducted a prospective observational non-inferiority study comparing three models of NIV care: general ward (Ward) (1:4 nurse to patient ratio, thrice weekly consultant ward round), a high dependency unit (HDU) (1:2 ratio, twice daily ward round) and an intensive care unit (ICU) (1:1 ratio, twice daily ward round) model in three similar teaching tertiary hospitals. Changes in arterial blood gases (ABG) and clinical outcomes were compared and corrected for differences in AECOPD severity (Blood urea > 9 mmol/L, Altered mental status (Glasgow coma scale (GCS) < 14), Pulse > 109 bpm, age > 65 (BAP-65)) and co-morbidities. An economic analysis was also undertaken. RESULTS: There was no significant difference in age (70 ± 10 years), forced expiratory volume in 1 s (FEV1 ) (0.84 ± 0.35 L), initial pH (7.29 ± 0.08), partial pressure of CO2 in arterial blood (PaCO2 ) (72 ± 22 mm Hg) or BAP-65 scores (2.9 ± 1.01) across the three models. The Ward achieved an increase in pH (0.12 ± 0.07) and a decrease in PaCO2 (12 ± 18 mm Hg) that was equivalent to HDU and ICU. However, the Ward treated more patients (38 vs 28 vs 15, P < 0.001), for a longer duration in the first 24 h (12.3 ± 4.8 vs 7.9 ± 4.1 vs 8.4 ± 5.3 h, P < 0.05) and was more cost-effective per treatment day ($AUD 1231 ± 382 vs 1745 ± 2673 vs 2386 ± 1120, P < 0.05) than HDU and ICU. ICU had a longer hospital stay (9 ± 11 vs 7 ± 7 vs 13 ± 28 days, P < 0.002) compared with the Ward and HDU. There was no significant difference in intubation rate or survival. CONCLUSION: In acute hypercapnic Chronic obstructive pulmonary disease (COPD) patients, the Ward model of NIV care achieved equivalent clinical outcomes, whilst being more cost-effective than HDU or ICU models.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Parker K, Perikala V, Aminazad A, et al. Models of care for non-invasive ventilation in the Acute COPD Comparison of three Tertiary hospitals (ACT3) study. Respirology. 2017. PMID: 29224257. doi:10.1111/resp.13228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。